Brielle Benyon | Authors


Helpful Markers for Immunotherapy Response May Lie With Mutations, irAEs

January 28, 2021

Results from the 2020 World Conference on Lung Cancer Singapore demonstrated the feasibility of using STK11 mutations and immune-related adverse events as response predictors in patients with non–small cell lung cancer.

Novel AI Tool Helps Patients to Find, Understand Clinical Trials

January 15, 2021 helped to match patients with gastrointestinal cancers to clinical trials using 7 different criteria, possibly paving the way for patients to find, understand, and enroll in oncology clinical trials.